Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
49.70    1.05 (2.16%)
Bid:
49.10
Ask:
49.70
Spread: 0.60 (1.222%)
Market Cap: £197.86m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Board Change

27 Nov 2008 15:30

CLS HOLDINGS PLC ("CLS" or "the Company") BOARD CHANGES

The Board of CLS Holdings plc is pleased to announce the appointment of Mr Joseph Crawley and Mr Chris Jarvis as Non-executive Directors with immediate effect.

In addition, Mr James Dean is to retire on 31st December 2008 as a Non-executive Director after over nine years of valuable service. James has also made an important contribution as a member of both the Audit Committee and of the Remuneration Committee, of which he was Chairman. Thomas Lundqvist and Joseph Crawley will be appointed as Chairman and Member of the Remuneration Committee respectively, Chris Jarvis will be appointed as a member of the Audit Committee and Malcolm Cooper will replace James as the Senior Independent Director. These committee changes are expected to take effect on 31st December 2008.

Joseph Crawley is Chief Executive of Kitewood Estates Ltd, a property investment and development company active in London and south-east England. Kitewood specialises in supplying residential property to housing associations and also has a commercial business which is developing a business park in Kent. Joe has considerable experience, knowledge and contacts relating to the central London property market and has been active in property development in the London area for over 20 years. He was previously employed by CLS from 1988 to 1991 when he was responsible for property development, including the development of the Spring Gardens site. He was CLS' Development Director from 1995 to September 1999.

Chris Jarvis FRICS is senior partner of Jarvis & Partners, a boutique real estate consultancy that he established in Berlin in 1994. Jarvis & Partners acquired a leading role in advising major tenants and owner occupiers in Germany with a client list including Linklaters, Clifford Chance and the European Central Bank. Jarvis & Partners' work has been involved in advising a number of German equity investors and working with German based international corporates on sale and leaseback deals in Europe. Prior to establishing Jarvis & Partners, Chris worked for Richard Ellis for 13 years in London and Germany, from 1988 to 1994 as Managing Director of Richard Ellis Germany.

Sten Mortstedt, Chairman, commented:

"We are delighted that Joe and Chris have agreed to join the Board. The Board thanks James for all he has done for CLS and wishes him well for the future."

Pursuant to Listing Rule 9.6.13 (3) Joseph Allen Crawley was an Executive Director of Groveclose Ltd which was voluntarily liquidated in 2001 and he resigned as a Director of Trinity Modular Technology Ltd on 1 October 1995 which was later put into liquidation in July 1996. No further information is required to be disclosed pursuant to LR 9.6.13 R. Joe does not have any beneficial interests in CLS ordinary shares.

No information is required to be disclosed pursuant to LR 9.6.13 R in respect of Christopher Patrick Jarvis and he does not have any beneficial interests in CLS ordinary shares.

Enquiries:

Sten Mortstedt, Executive Chairman, CLS Holdings plc +44 (0) 20 7582 7766

Henry Klotz, Chief Executive Officer, CLS Holdings plc +44 (0) 20 7582 7766

vendor
Date   Source Headline
5th Oct 20225:13 pmRNSDirector/PDMR Shareholding
4th Oct 20221:12 pmRNSDirector/PDMR Shareholding
29th Sep 202211:26 amRNSDirector/PDMR Shareholding
23rd Sep 20223:06 pmRNSDirector/PDMR Shareholding
22nd Sep 20223:41 pmRNSDirector/PDMR Shareholding
16th Sep 20224:56 pmRNSCompletion of Tender Offer and Total Voting Rights
15th Sep 20223:57 pmRNSDirector/PDMR Shareholding
12th Sep 20224:14 pmRNSResult of Tender Offer
9th Sep 202212:23 pmRNSResult of AGM
15th Aug 20224:27 pmRNSTender Offer
10th Aug 20224:19 pmRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSHalf-year Results
3rd Aug 20227:00 amRNSCLS announces the sale of three properties
2nd Aug 20225:38 pmRNSNotice of Results
14th Jul 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 202210:31 amRNSCLS reclassified as REIT on EPRA index
9th Jun 20222:09 pmRNSDirector/PDMR Shareholding
12th May 20222:05 pmRNSDirector/PDMR Shareholding
12th May 20222:01 pmRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSDividend Policy Update
28th Apr 20223:24 pmRNSAGM Statement
14th Apr 202211:20 amRNSDirector/PDMR Shareholding
28th Mar 20224:19 pmRNSAnnual Financial Report
18th Mar 202212:54 pmRNSDirector/PDMR Shareholding
18th Mar 202212:52 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSAnnual Financial Report
9th Mar 20225:42 pmRNSDirector/PDMR Shareholding
8th Mar 20227:00 amRNSAcquisition
17th Feb 20227:00 amRNSAcquisition
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
10th Feb 20222:55 pmRNSHolding(s) in Company
9th Feb 20223:50 pmRNSDirector/PDMR Shareholding
9th Feb 202211:50 amRNSDirector/PDMR Shareholding
3rd Feb 202210:10 amRNSNotice of Results
26th Jan 202211:51 amRNSDirector/PDMR Shareholding
10th Jan 202211:43 amRNSDirector/PDMR Shareholding
29th Dec 20211:07 pmRNSConversion of UK operations to a REIT
21st Dec 20216:25 pmRNSPDMR Notification
16th Dec 20217:00 amRNSCLS secures five new leases in Germany
9th Dec 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20219:52 amRNSDirector Declaration
11th Nov 202111:40 amRNSDirector/PDMR Shareholding
9th Nov 20219:24 amRNSDirector/PDMR Shareholding
3rd Nov 20217:00 amRNSTrading Update
13th Oct 20217:00 amRNSDirector/PDMR Shareholding
30th Sep 20217:00 amRNSCLS secures two new leases in Germany
20th Sep 20215:43 pmRNSDirector/PDMR Shareholding
10th Sep 20215:26 pmRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNSChange of Auditor
11th Aug 20217:00 amRNSSustainability strategy launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.